SCHEMBL26415446

SCHEMBL26415446

c1ccc(-c2ccc(N(c3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c4c(c3)oc3ccccc34)c3cccc4ccccc34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.33
TSHR P16473 4/20 0.33
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 3/20 0.33
HSD17B10 Q99714 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 2/20 0.32
LMNA P02545 2/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
NR1H4 Q96RI1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26416884 0.96 MAPT (0.34) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL24066184 0.93 MAPT (0.33) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL24066080 0.90 TSHR (0.33) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL22112409 0.90 ALDH1A1 (0.34) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL25666458 0.90 MAPT (0.32) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL24899588 0.90 MAPT (0.35) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL26420459 0.90 MAPT (0.35) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL24255426 0.89 ALDH1A1 (0.34) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL24255395 0.89 ALDH1A1 (0.34) MAPTTSHRKDM4EALDH1A1HPGD
SCHEMBL26415598 0.88 MAPT (0.35) MAPTTSHRKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 MAPT 950/4885TSHR 4641/4885KDM4E 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.